Show simple item record

dc.contributor.authorMaru, Shoko
dc.contributor.authorByrnes, Joshua
dc.contributor.authorCarrington, Melinda J
dc.contributor.authorStewart, Simon
dc.contributor.authorScuffham, Paul A
dc.date.accessioned2018-06-25T00:35:22Z
dc.date.available2018-06-25T00:35:22Z
dc.date.issued2015
dc.identifier.issn1473-7167
dc.identifier.doi10.1586/14737167.2015.1046842
dc.identifier.urihttp://hdl.handle.net/10072/141322
dc.description.abstractSubstantial variation in economic analyses of cardiovascular disease management programs hinders not only the proper assessment of cost–effectiveness but also the identification of heterogeneity of interest such as patient characteristics. The authors discuss the impact of reporting and methodological variation on the cost–effectiveness of cardiovascular disease management programs by introducing issues that could lead to different policy or clinical decisions, followed by the challenges associated with net intervention effects and generalizability. The authors conclude with practical suggestions to mitigate the identified issues. Improved transparency through standardized reporting practice is the first step to advance beyond one-off experiments (limited applicability outside the study itself). Transparent reporting is a prerequisite for rigorous cost–effectiveness analyses that provide unambiguous implications for practice: what type of program works for whom and how.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherTaylor & Francis
dc.relation.ispartofpagefrom657
dc.relation.ispartofpageto666
dc.relation.ispartofissue4
dc.relation.ispartofjournalExpert Review of Pharmacoeconomics and Outcomes Research
dc.relation.ispartofvolume15
dc.subject.fieldofresearchPharmacology and Pharmaceutical Sciences not elsewhere classified
dc.subject.fieldofresearchPharmacology and Pharmaceutical Sciences
dc.subject.fieldofresearchPublic Health and Health Services
dc.subject.fieldofresearchApplied Economics
dc.subject.fieldofresearchcode111599
dc.subject.fieldofresearchcode1115
dc.subject.fieldofresearchcode1117
dc.subject.fieldofresearchcode1402
dc.titleEconomic implications of cardiovascular disease management programs: moving beyond one-off experiments
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.facultyGriffith Health, School of Medicine
gro.hasfulltextNo Full Text
gro.griffith.authorScuffham, Paul A.
gro.griffith.authorByrnes, Joshua M.
gro.griffith.authorMaru, Shoko


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record